Plasma activated coating immobilizes apolipoprotein A-I to stainless steel surfaces in its bioactive form and enhances biocompatibility

Laura Z. Vanags, Joanne T.M. Tan, Miguel Santos, Praveesuda S. Michael, Ziad Ali, Marcela M.M. Bilek, Steven G. Wise, Christina A. Bursill

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We utilized a plasma activated coating (PAC) to covalently bind the active component of high density lipoproteins (HDL), apolipoprotein (apo) A-I, to stainless steel (SS) surfaces. ApoA-I suppresses restenosis and thrombosis and may therefore improve SS stent biocompatibility. PAC-coated SS significantly increased the covalent attachment of apoA-I, compared to SS alone. In static and dynamic flow thrombosis assays, PAC + apoA-I inhibited thrombosis and reduced platelet activation marker p-selectin. PAC + apoA-I reduced smooth muscle cell attachment and proliferation, and augmented EC attachment to PAC. We then coated PAC onto murine SS stents and found it did not peel or delaminate following crimping/expansion. ApoA-I was immobilized onto PAC-SS stents and was retained as a monolayer when exposed to pulsatile flow in vivo in a murine stent model. In conclusion, ApoA-I immobilized on PAC withstands pulsatile flow in vivo and retains its bioactivity, exhibiting anti-thrombotic and anti-restenotic properties, demonstrating the potential to improve stent biocompatibility.

LanguageEnglish
Pages2141-2150
Number of pages10
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume13
Issue number7
DOIs
Publication statusPublished - 1 Oct 2017
Externally publishedYes

Keywords

  • Apolipoprotein A-I
  • Biocompatibility
  • Plasma deposition
  • Stent
  • Thrombosis

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Molecular Medicine
  • Biomedical Engineering
  • Materials Science(all)
  • Pharmaceutical Science

Cite this

Vanags, Laura Z. ; Tan, Joanne T.M. ; Santos, Miguel ; Michael, Praveesuda S. ; Ali, Ziad ; Bilek, Marcela M.M. ; Wise, Steven G. ; Bursill, Christina A. / Plasma activated coating immobilizes apolipoprotein A-I to stainless steel surfaces in its bioactive form and enhances biocompatibility. In: Nanomedicine: Nanotechnology, Biology, and Medicine. 2017 ; Vol. 13, No. 7. pp. 2141-2150.
@article{d5010c0e533241958738294d5d853b2b,
title = "Plasma activated coating immobilizes apolipoprotein A-I to stainless steel surfaces in its bioactive form and enhances biocompatibility",
abstract = "We utilized a plasma activated coating (PAC) to covalently bind the active component of high density lipoproteins (HDL), apolipoprotein (apo) A-I, to stainless steel (SS) surfaces. ApoA-I suppresses restenosis and thrombosis and may therefore improve SS stent biocompatibility. PAC-coated SS significantly increased the covalent attachment of apoA-I, compared to SS alone. In static and dynamic flow thrombosis assays, PAC + apoA-I inhibited thrombosis and reduced platelet activation marker p-selectin. PAC + apoA-I reduced smooth muscle cell attachment and proliferation, and augmented EC attachment to PAC. We then coated PAC onto murine SS stents and found it did not peel or delaminate following crimping/expansion. ApoA-I was immobilized onto PAC-SS stents and was retained as a monolayer when exposed to pulsatile flow in vivo in a murine stent model. In conclusion, ApoA-I immobilized on PAC withstands pulsatile flow in vivo and retains its bioactivity, exhibiting anti-thrombotic and anti-restenotic properties, demonstrating the potential to improve stent biocompatibility.",
keywords = "Apolipoprotein A-I, Biocompatibility, Plasma deposition, Stent, Thrombosis",
author = "Vanags, {Laura Z.} and Tan, {Joanne T.M.} and Miguel Santos and Michael, {Praveesuda S.} and Ziad Ali and Bilek, {Marcela M.M.} and Wise, {Steven G.} and Bursill, {Christina A.}",
year = "2017",
month = "10",
day = "1",
doi = "10.1016/j.nano.2017.06.012",
language = "English",
volume = "13",
pages = "2141--2150",
journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",
issn = "1549-9634",
publisher = "Elsevier Inc.",
number = "7",

}

Plasma activated coating immobilizes apolipoprotein A-I to stainless steel surfaces in its bioactive form and enhances biocompatibility. / Vanags, Laura Z.; Tan, Joanne T.M.; Santos, Miguel; Michael, Praveesuda S.; Ali, Ziad; Bilek, Marcela M.M.; Wise, Steven G.; Bursill, Christina A.

In: Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 13, No. 7, 01.10.2017, p. 2141-2150.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Plasma activated coating immobilizes apolipoprotein A-I to stainless steel surfaces in its bioactive form and enhances biocompatibility

AU - Vanags, Laura Z.

AU - Tan, Joanne T.M.

AU - Santos, Miguel

AU - Michael, Praveesuda S.

AU - Ali, Ziad

AU - Bilek, Marcela M.M.

AU - Wise, Steven G.

AU - Bursill, Christina A.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - We utilized a plasma activated coating (PAC) to covalently bind the active component of high density lipoproteins (HDL), apolipoprotein (apo) A-I, to stainless steel (SS) surfaces. ApoA-I suppresses restenosis and thrombosis and may therefore improve SS stent biocompatibility. PAC-coated SS significantly increased the covalent attachment of apoA-I, compared to SS alone. In static and dynamic flow thrombosis assays, PAC + apoA-I inhibited thrombosis and reduced platelet activation marker p-selectin. PAC + apoA-I reduced smooth muscle cell attachment and proliferation, and augmented EC attachment to PAC. We then coated PAC onto murine SS stents and found it did not peel or delaminate following crimping/expansion. ApoA-I was immobilized onto PAC-SS stents and was retained as a monolayer when exposed to pulsatile flow in vivo in a murine stent model. In conclusion, ApoA-I immobilized on PAC withstands pulsatile flow in vivo and retains its bioactivity, exhibiting anti-thrombotic and anti-restenotic properties, demonstrating the potential to improve stent biocompatibility.

AB - We utilized a plasma activated coating (PAC) to covalently bind the active component of high density lipoproteins (HDL), apolipoprotein (apo) A-I, to stainless steel (SS) surfaces. ApoA-I suppresses restenosis and thrombosis and may therefore improve SS stent biocompatibility. PAC-coated SS significantly increased the covalent attachment of apoA-I, compared to SS alone. In static and dynamic flow thrombosis assays, PAC + apoA-I inhibited thrombosis and reduced platelet activation marker p-selectin. PAC + apoA-I reduced smooth muscle cell attachment and proliferation, and augmented EC attachment to PAC. We then coated PAC onto murine SS stents and found it did not peel or delaminate following crimping/expansion. ApoA-I was immobilized onto PAC-SS stents and was retained as a monolayer when exposed to pulsatile flow in vivo in a murine stent model. In conclusion, ApoA-I immobilized on PAC withstands pulsatile flow in vivo and retains its bioactivity, exhibiting anti-thrombotic and anti-restenotic properties, demonstrating the potential to improve stent biocompatibility.

KW - Apolipoprotein A-I

KW - Biocompatibility

KW - Plasma deposition

KW - Stent

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=85024476952&partnerID=8YFLogxK

U2 - 10.1016/j.nano.2017.06.012

DO - 10.1016/j.nano.2017.06.012

M3 - Article

VL - 13

SP - 2141

EP - 2150

JO - Nanomedicine: Nanotechnology, Biology, and Medicine

T2 - Nanomedicine: Nanotechnology, Biology, and Medicine

JF - Nanomedicine: Nanotechnology, Biology, and Medicine

SN - 1549-9634

IS - 7

ER -